Certolizumab pegol/isoniazidTuberculosis and lack of efficacy: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2022年 / 1928卷 / 1期
关键词：
D O I：
10.1007/s40278-022-25387-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：122 / 122
相关论文
共 50 条
  • [31] Certolizumab-pegol/leflunomide/methotrexateAccelerated pulmonary nodulosis: case report
    Reactions Weekly, 2025, 2044 (1) : 92 - 92
  • [32] Certolizumab pegol/immunosuppressantsMoraxella catarrhalis periprosthetic joint infection: case report
    Reactions Weekly, 2017, 1664 (1) : 77 - 77
  • [33] Certolizumab pegol/corticosteroidsListeria monocytogenes infection presented as bacteraemia: case report
    Reactions Weekly, 2015, 1551 (1) : 70 - 70
  • [34] Certolizumab pegol/etanerceptRespiratory tract infections and tertiary syphilis: case report
    Reactions Weekly, 2019, 1749 (1) : 122 - 122
  • [35] Severe Cutaneous Psoriasis After Certolizumab Pegol Treatment: Report of a Case
    Mocciaro, Filippo
    Renna, Sara
    Orlando, Ambrogio
    Cottone, Mario
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (11): : 2867 - 2868
  • [36] Efficacy of certolizumab pegol: a case study in a patient with rheumatoid arthritis on maintenance hemodialysis
    Nishimura, Akito
    Minegishi, Yohjiroh
    Kwamura, Keiko
    Ichino, Asako
    Uchiyama, Katsufumi
    RHEUMATOLOGY INTERNATIONAL, 2015, 35 (09) : 1601 - 1602
  • [37] Efficacy of certolizumab pegol: a case study in a patient with rheumatoid arthritis on maintenance hemodialysis
    Akito Nishimura
    Yohjiroh Minegishi
    Keiko Kwamura
    Asako Ichino
    Katsufumi Uchiyama
    Rheumatology International, 2015, 35 : 1601 - 1602
  • [38] Certolizumab pegol
    Goel, Niti
    Stephens, Sue
    MABS, 2010, 2 (02) : 137 - 147
  • [39] Certolizumab pegol
    Delgado Frias, Esmeralda
    Diaz Gonzalez, Jose Federico
    REUMATOLOGIA CLINICA, 2011, 6 : S7 - S11
  • [40] Certolizumab pegol
    Gil Y. Melmed
    Stephan R. Targan
    Uma Yasothan
    Delphine Hanicq
    Peter Kirkpatrick
    Nature Reviews Drug Discovery, 2008, 7 : 641 - 642
12345